Nasdaq Apto News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq apto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Apto Today - Breaking & Trending Today
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 54,900 shares, a decline of 35.9% from the March 31st total of 85,600 shares. Approximately 0.6% of the company’s stock are sold short. Based on […] ....
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 54,900 shares, a decline of 35.9% from the March 31st total of 85,600 shares. Based on an average daily trading volume, of […] ....
Shares of Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) have been assigned a consensus recommendation of “Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have updated their coverage on […] ....
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 85,600 shares, a growth of 70.5% from the March 15th total of 50,200 shares. Currently, 0.9% of the shares of the company […] ....
Aptose Biosciences (NASDAQ:APTO – Get Free Report) and Sutro Biopharma (NASDAQ:STRO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Risk & Volatility Aptose Biosciences has a […] ....